Filing status
- Accounts due
- 30 July 2027
- Conf. stmt due
- 12 November 2027
- Last conf. stmt
- 29 October 2026
Fibrx Therapeutics Ltd
- Incorporated
- 30 October 2025 (1 year)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Peter Collum
- Owned by
- Region
- North West
- Address
- Block 11Suite 5F MeresideAlderley ParkMacclesfieldSK10 4TG
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Collum, Peter
Director · Appointed 30 October 2025
American
Born June 1972 (54)
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 30 October 2025
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 07368089
Group structure 4 companies
Ownership group derived from the Companies House PSC register
Fibrx Therapeutics Ltd This company Owns 75–100% of shares
Redx Immunology Limited Owns 75–100% of shares
Redx Oncology Ltd Owns 75–100% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 6 November 2026 | Confirmation statement with no updates | 29 October 2026 |
Some other companies at this address
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →